Emerging Technologies series

Dave Rosa, president and CEO of NeuroOne, joins MobihealthNews for Part 2 of the Emerging Technologies series to discuss the company's thin-film electrode technology.

The CEO of NeuroOne, Dave Rosa, discusses the company's minimally invasive brain-computer interface thin-film, flexible electrode technology, its successes in patients with seizures and the potential benefits across a range of neurological conditions.

In Part 1 of Season 2 of MobiHealthNews’ Emerging Technologies series, Mark Zhang, acting assistant under secretary for health, explains how innovation is scaling across the VA.

Acting assistant under secretary for health at the U.S. Department of Veterans Affairs at the U.S. Department of Veterans Affairs, Dr. Mark Zhang, discusses the VA's research into 3D-printed biological material for veterans.

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.

Nissan Elimelech, founder of Augmedics, discusses the process of developing augmented reality surgical navigation technology and his next endeavor to develop the first AR glasses specifically for healthcare.

Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.

Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.